TRLV
Trulieve Cannabis Corp.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
10.60
close · 2026-10-29
value
61
cheaper than peers61
quality
23
stronger fundamentals23
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 6.42× | 87 |
| price to sales | 1.53× | 72 |
| price to book | 2.66× | 53 |
| forward P/E | 18.82× | 23 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 12.8% | 66 |
| debt to equity | 75.4% | 50 |
| return on equity | -47.6% | 19 |
| revenue growth | -10.3% | 18 |
4 of 4 measures available
Facts
| market cap | $2B |
| free cash flow | $231.8M |
| employees | 5,000 |
| first trade | 2018-09-27 |
| next earnings | 2026-11-05 |
| fundamentals updated | 2026-08-10 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.61 | -0.82 | -2.79 | -1.31 |
| free cash flow | $212.3M | $123.8M | $151.0M | -$170.7M |
| net income | -$116.4M | -$155.1M | -$526.8M | -$246.1M |
| revenue | $1.18B | $1.19B | $1.13B | $1.22B |
| unusual items | -$6.5M | $5.3M | -$308.3M | -$75.5M |